Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The SHC (Src homology 2 domain containing) transforming protein 1 pseudogene refers to a genomic DNA sequence in humans that closely resembles the SHC1 gene, which encodes a protein involved in signal transduction by acting as an adaptor in receptor tyrosine kinase pathways[1][4]. However, as a pseudogene, it does not encode a functional protein product because of disabling mutations that prevent transcription or translation[2][5]. Pseudogenes are generally considered non-functional remnants of genes; some can have a regulatory role, but most lack any direct protein-coding or canonical molecular activity[2][5]. SHC1 and related SHC proteins play critical roles in cell signaling, particularly in pathways mediated by receptor tyrosine kinases, but the SHC1 pseudogene itself is not a therapeutic or biological target and does not produce a functional SHC protein[1][2][4][5]. The gene identifier ENSG00000283269 refers to a pseudogene, and not to any functional gene or protein.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SHC (Src homology 2 domain containing) transforming protein 1 pseudogene.